REFERENCES
V. Levi, J. C. Scott, P. F. White, and W. Sadée. Pharm. Res. 4:46–49 (1987).
A. M. Falick, H. G. Wang, and F. C. Walls. Anal. Chem. 58:1308–1311 (1986).
A. Rezvani, J. P. Huidobro-Toro, J. Hu, and E. L. Way. J. Pharmacol. Exp. Ther. 225:251–255 (1983).
G. Krowech, P. S. Caldera-Munoz, K. Straub, N. Castagnoli, and M. A. Correia. Chem. Biol. Interact. 58:29–40 (1986).
S. Okuda, S. Yamaguchi, Y. Kawazoe, and K. Tsuda. Chem. Pharm. Bull. 12:104–112 (1964).
H. Rapaport and S. Masamune, J. Am. Chem. Soc. 77:6359–6361 (1955).
B. Proksa, Z. Voticky, L. Molnar, J. Putek, and M. Stefek. Chem. Zvesti 32:710–714 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farsam, H., Eiger, S., Lameh, J. et al. Morphine Impurity with Opioid Activity Is Identified as 10α-Hydroxymorphine. Pharm Res 7, 1205–1207 (1990). https://doi.org/10.1023/A:1015957031449
Issue Date:
DOI: https://doi.org/10.1023/A:1015957031449